株探米国株
日本語 英語
エドガーで原本を確認する
November 6, 20250001159167false00011591672025-11-062025-11-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934


Date of report (Date of earliest event reported): November 6, 2025


 iROBOT CORPORATION 

(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
001-36414 77-0259335
(Commission File Number) (I.R.S. Employer
Identification No.)

8 Crosby Drive
Bedford, MA 01730
(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (781) 430-3000


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value IRBT The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).




Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨



Item 2.02
Results of Operations and Financial Condition.
On November 6, 2025, the Company announced its financial results for the fiscal quarter ended September 27, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8‑K.
The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (“Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No. Description
Press Release issued by the registrant on November 6, 2025, furnished herewith.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 6, 2025
iRobot Corporation
By: /s/ Kevin Lanouette
Name: Kevin Lanouette
Title: SVP & General Counsel


























EX-99.1 2 ex991q32025pressrelease.htm EX-99.1 Document

EX-99.1
Contacts:
Investor Relations Michèle Szynal
iRobot Corp. Corporate Communications
(781) 430-3003 iRobot Corp.
investorrelations@irobot.com (508) 751-2689
mszynal@irobot.com
iRobot Reports Third-Quarter 2025 Financial Results

BEDFORD, Mass. - iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the third quarter ended September 27, 2025.
“Our third-quarter revenue fell well below our internal expectations due to continuing market headwinds, ongoing production delays, and unforeseen shipping disruptions,” said Gary Cohen, iRobot CEO. “This shortfall increased cash usage and pressured profitability, as we were unable to fully leverage our fixed cost base.”
Third Quarter 2025 Financial Results (in millions, except per share amounts and percentages)
Q3 2025 Q3 2024
Revenue $145.8 $193.4
GAAP Gross Margin 31.0% 32.2%
Non-GAAP Gross Margin 31.2% 32.4%
GAAP Operating Expenses $62.9 $55.1
Non-GAAP Operating Expenses $55.4 $47.7
GAAP Operating (Loss) Income ($17.7) $7.3
Non-GAAP Operating (Loss) Income ($9.9) $15.1
GAAP Net Loss Per Share ($0.62) ($0.21)
Non-GAAP Net (Loss) Income Per Share ($0.23) $0.03
Balance Sheet and Operational Highlights
•As of September 27, 2025, the Company’s cash and cash equivalents totaled $24.8 million, compared with $40.6 million as of June 28, 2025. As of September 27, 2025, the Company had an additional $5.0 million in restricted cash, which was fully drawn on September 30, 2025. At this time, Company has no sources upon which it can draw for additional capital.
•As of September 27, 2025, the Company’s inventory totaled $140.9 million, compared with $149.2 million in the third quarter of 2024.
•In the third quarter of 2025, revenue declined 33% in the U.S., declined 13% in EMEA and declined 9% in Japan over the prior-year period. Excluding the foreign currency impact, EMEA revenue declined 14% while Japan remained flat over the prior-year period.



•Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 74% of total robot sales in the third quarter of 2025 versus 79% from the same period last year.
Strategic Review Process
The Company refers investors to its Form 10-Q filed with the SEC on November 6, 2025 for details regarding its previously announced strategic review process.
About iRobot
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold millions of robots worldwide. iRobot’s product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company’s profitability and near-term capital requirements, and the strategic review process. These forward-looking statements are based on the Company’s current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the Company’s control, and are not guarantees of future results. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company’s ability to obtain new capital in the near term, if at all; (ii) the Company’s ability to realize the benefits of its operational restructuring; (iii) the impact of various global conflicts on the Company’s business and general economic conditions; (iv) the Company’s ability to implement its business strategy; (v) the risk that disruptions from the Company’s operational restructuring will harm its business, including current plans and operations; (vi) the ability of the Company to retain and hire skilled personnel; (vii) loss of any key employee; (viii) failure of the Company’s primary contract manufacturer to meet the Company’s requirements; (ix) legislative, regulatory and economic developments affecting the Company’s business; (x) general economic and market developments and conditions; (xi) the evolving legal, regulatory and tax regimes under which the Company operates; (xii) potential business uncertainty, including changes to existing business relationships that could affect the Company’s financial performance; (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xiv) current supply chain challenges; (xv) the financial strength of the Company’s customers and retailers; (xvi) the impact of any applicable tariffs on goods imported into the United States; (xvii) competition; (xviii) cybersecurity risks; (xix) failure to obtain additional waivers from the Company’s lenders of the Company’s obligation to comply with certain covenants under the Company’s credit agreement; and (xx) the results and impact of the Board’s strategic review of alternatives for the business, as well as the Company’s response to any of the aforementioned factors.



Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
###
iRobot Contacts
Public Relations: mszynal@irobot.com
Investor Relations: InvestorRelations@irobot.com





iRobot Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
For the three months ended For the nine months ended
September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024
Revenue $ 145,832  $ 193,435  $ 374,959  $ 509,811 
Cost of revenue:
Cost of product revenue 100,580  131,058  269,437  383,865 
Restructuring and other —  —  1,658  — 
Total cost of revenue 100,580  131,058  271,095  383,865 
Gross profit 45,252  62,377  103,864  125,946 
Operating expenses:
Research and development 13,094  19,630  41,547  76,739 
Selling and marketing 29,256  29,270  94,310  98,966 
General and administrative 20,346  3,232  60,430  (33,552)
Restructuring and other 81  1,922  7,287  24,298 
Amortization of acquired intangible assets 146  1,066  427  1,405 
Total operating expenses 62,923  55,120  204,001  167,856 
Operating (loss) income (17,671) 7,257  (100,137) (41,910)
Other expense, net (711) (12,548) (28,391) (24,583)
Loss before income taxes (18,382) (5,291) (128,528) (66,493)
Income tax expense 3,144  1,080  3,079  1,917 
Net loss $ (21,526) $ (6,371) $ (131,607) $ (68,410)
Net loss per share:
Basic $ (0.62) $ (0.21) $ (3.97) $ (2.34)
Diluted $ (0.62) $ (0.21) $ (3.97) $ (2.34)
Number of shares used in per share calculations:
Basic 34,866  30,348  33,128  29,276 
Diluted 34,866  30,348  33,128  29,276 
Stock-based compensation included in above figures:
Cost of revenue $ 277  $ 387  $ 820  $ 1,486 
Research and development 554  1,296  2,221  4,994 
Selling and marketing 717  903  2,490  3,403 
General and administrative 2,306  2,894  7,399  8,054 
Total $ 3,854  $ 5,480  $ 12,930  $ 17,937 






 iRobot Corporation
 Condensed Consolidated Balance Sheets
 (unaudited, in thousands)
September 27, 2025 December 28, 2024
 Assets
 Cash and cash equivalents $ 24,828  $ 134,303 
 Restricted cash 5,000  1,259 
 Accounts receivable, net 56,813  49,865 
 Inventory 140,910  76,029 
 Other current assets 20,919  27,046 
Total current assets 248,470  288,502 
 Property and equipment, net 9,850  15,835 
 Operating lease right-of-use assets 12,259  14,322 
 Deferred tax assets 10,162  9,817 
 Goodwill 182,450  167,288 
 Intangible assets, net 3,086  3,212 
 Other assets 15,296  17,161 
Total assets $ 481,573  $ 516,137 
 Liabilities and stockholders' (deficit) equity
 Accounts payable $ 197,047  $ 106,367 
 Accrued expenses 70,606  100,597 
 Deferred revenue and customer advances 7,931  11,280 
 Term loan 205,292  — 
Total current liabilities 480,876  218,244 
 Term loan —  200,604 
 Operating lease liabilities 17,762  21,598 
 Other long-term liabilities 9,820  14,452 
Total long-term liabilities 27,582  236,654 
Total liabilities 508,458  454,898 
 Stockholders' (deficit) equity (26,885) 61,239 
Total liabilities and stockholders' (deficit) equity $ 481,573  $ 516,137 




 iRobot Corporation
Consolidated Statements of Cash Flows
 (unaudited, in thousands)
For the nine months ended
September 27, 2025 September 28, 2024
Cash flows from operating activities:
Net loss $ (131,607) $ (68,410)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 5,919  16,912 
Loss on equity investment 1,566  375 
Stock-based compensation 12,930  17,937 
Provision for inventory excess and obsolescence 1,340  11,800 
Change in fair value of term loan (1,079) 13,515 
Debt issuance costs associated with warrants issued 16,828  — 
Debt issuance costs expensed under fair value option —  529 
Deferred income taxes, net 4,659  (651)
Other 4,600  (6,318)
Changes in operating assets and liabilities — (use) source
Accounts receivable (4,814) (22,073)
Inventory (66,663) (10,539)
Other assets 5,815  15,598 
Accounts payable 89,967  16,674 
Accrued expenses and other liabilities (43,664) (15,825)
Net cash used in operating activities (104,203) (30,476)
Cash flows from investing activities:
Additions of property and equipment —  (118)
Purchase of investments (14) (56)
Sales and maturities of investments 594  — 
Net cash provided by (used in) investing activities 580  (174)
Cash flows from financing activities:
Income tax withholding payment associated with restricted stock vesting (371) (491)
Proceeds from issuance of common stock, net of issuance costs —  19,359 
Repayment of term loan (4,000) (34,947)
Payment of debt issuance costs —  (529)
Net cash used in financing activities (4,371) (16,608)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,856  1,251 
Net decrease in cash, cash equivalents and restricted cash (106,138) (46,007)
Cash, cash equivalents and restricted cash, at beginning of period 137,951  187,887 
Cash, cash equivalents and restricted cash, at end of period $ 31,813  $ 141,880 
Cash, cash equivalents and restricted cash, at end of period:
Cash and cash equivalents $ 24,828  $ 99,447 
Restricted cash 5,000  41,082 
Restricted cash, non-current (included in other assets) 1,985  1,351 
Cash, cash equivalents and restricted cash, at end of period $ 31,813  $ 141,880 



 iRobot Corporation
Supplemental Information
(unaudited)
For the three months ended For the nine months ended
September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024
Revenue by Geographical Region *
United States $ 70,772  $ 105,137  $ 168,653  $ 258,398 
EMEA 39,733  45,902  105,933  130,884 
Japan 25,138  27,718  76,511  83,254 
Other 10,189  14,678  23,862  37,275 
Total $ 145,832  $ 193,435  $ 374,959  $ 509,811 
Robot Units Shipped *
    2-in-1 498  445  1,263  908 
    Solo and other 57  287  218  854 
Total 555  732  1,481  1,762 
Revenue by Product Category **
    2-in-1 $ 124  $ 110  $ 289  $ 242 
    Solo and other 22  83  86  268 
Total $ 146  $ 193  $ 375  $ 510 
Average gross selling prices for robot units $ 330  $ 313  $ 311  $ 329 
Headcount 492  661 
* in thousands
** in millions
Certain numbers may not total due to rounding



iRobot Corporation
Explanation of Non-GAAP Measures
In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.
Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Amortization of Acquired Intangible Assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of professional fees associated with mergers, acquisitions and the review of strategic alternatives, including, but not limited to, exploring a potential sale or strategic transaction. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.
Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, costs associated with early termination of contracts, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments.



We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.
Debt Issuance Costs: Debt issuance costs include various incremental fees paid to third parties and warrants issued in connection with the issuance or amendment of debt.
Income Tax Adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowance based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.



iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals
(in thousands, except per share amounts)
(unaudited)
For the three months ended For the nine months ended
September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024
 GAAP Revenue $ 145,832  $ 193,435  $ 374,959  $ 509,811 
 GAAP Gross Profit $ 45,252  $ 62,377  $ 103,864  $ 125,946 
Stock-based compensation 277  387  820  1,486 
Restructuring and other —  —  1,658  — 
 Non-GAAP Gross Profit $ 45,529  $ 62,764  $ 106,342  $ 127,432 
 GAAP Gross Margin 31.0  % 32.2  % 27.7  % 24.7  %
 Non-GAAP Gross Margin 31.2  % 32.4  % 28.4  % 25.0  %
 GAAP Operating Expenses $ 62,923  $ 55,120  $ 204,001  $ 167,856 
Amortization of acquired intangible assets (146) (1,066) (427) (1,405)
Stock-based compensation (3,577) (5,093) (12,110) (16,451)
Net merger, acquisition and divestiture (expense) income (3,704) 656  (9,422) 74,813 
Restructuring and other (81) (1,922) (7,287) (24,298)
 Non-GAAP Operating Expenses $ 55,415  $ 47,695  $ 174,755  $ 200,515 
 GAAP Operating Expenses as a % of GAAP Revenue 43.1  % 28.5  % 54.4  % 32.9  %
 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue 38.0  % 24.7  % 46.6  % 39.3  %
 GAAP Operating (Loss) Income $ (17,671) $ 7,257  $ (100,137) $ (41,910)
Amortization of acquired intangible assets 146  1,066  427  1,405 
Stock-based compensation 3,854  5,480  12,930  17,937 
Net merger, acquisition and divestiture expense (income) 3,704  (656) 9,422  (74,813)
Restructuring and other 81  1,922  8,945  24,298 
 Non-GAAP Operating (Loss) Income $ (9,886) $ 15,069  $ (68,413) $ (73,083)
 GAAP Operating Margin (12.1) % 3.8  % (26.7) % (8.2) %
 Non-GAAP Operating Margin (6.8) % 7.8  % (18.2) % (14.3) %



iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued
(in thousands, except per share amounts)
(unaudited)
For the three months ended For the nine months ended
September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024
 GAAP Income Tax Expense
$ 3,144  $ 1,080  $ 3,079  $ 1,917 
Tax effect of non-GAAP adjustments 43  650  269  1,667 
Other tax adjustments (2,854) (203) (2,063) (811)
 Non-GAAP Income Tax Expense $ 333  $ 1,527  $ 1,285  $ 2,773 
 GAAP Net Loss $ (21,526) $ (6,371) $ (131,607) $ (68,410)
Amortization of acquired intangible assets 146  1,066  427  1,405 
Stock-based compensation 3,854  5,480  12,930  17,937 
Net merger, acquisition and divestiture expense (income) 3,704  (656) 9,422  (74,813)
Restructuring and other 81  1,922  8,945  24,298 
Loss on strategic investments 1,960  —  1,566  375 
Debt issuance costs 944  52  19,580  529 
Income tax effect 2,811  (447) 1,794  (856)
 Non-GAAP Net (Loss) Income $ (8,026) $ 1,046  $ (76,943) $ (99,535)
 GAAP Net Loss Per Diluted Share $ (0.62) $ (0.21) $ (3.97) $ (2.34)
Amortization of acquired intangible assets —  0.03  0.01  0.05 
Stock-based compensation 0.11  0.18  0.39  0.61 
Net merger, acquisition and divestiture expense (income) 0.11  (0.02) 0.29  (2.55)
Restructuring and other —  0.06  0.27  0.83 
Loss on strategic investments 0.06  —  0.05  0.01 
Debt issuance costs 0.03  —  0.59  0.02 
Income tax effect 0.08  (0.01) 0.05  (0.03)
 Non-GAAP Net (Loss) Income Per Diluted Share $ (0.23) $ 0.03  $ (2.32) $ (3.40)
Number of shares used in diluted per share calculation 34,866  30,551  33,128  29,276 
Supplemental Information
Days sales outstanding 36  48 
GAAP Days in inventory 128  104 
Non-GAAP Days in inventory(1)
128  104 
(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days.